Site Trust & Methodology
About the Regulatory Status of Everything on This Site
The long version of the disclosure on our homepage — every product and offer, stated plainly.
This site links to two fundamentally different kinds of offers. We think the difference matters enough to spell out in full, not just in a footnote.
| HealthyRXs Catalog | Healthymale Offer | |
|---|---|---|
| FDA-approved | No | Prescribed medication, dispensed via licensed U.S. pathway |
| Prescriber review | No | Yes |
| Based | International (Cyprus-based distributor) | U.S.-based telehealth via Secure Medical |
| Manufacturing oversight | Not FDA-regulated; may vary by manufacturer | FDA-regulated pharmaceutical supply chain |
The HealthyRXs catalog, in full
HealthyRXs is an international healthcare exporter and distributor based outside the United States. Every product in the comparison table and featured-products section on this site — Sildatron-100, Megalis 20, Sildatron D, and the vardenafil and avanafil listings — is sourced through HealthyRXs and is not FDA-approved. These products have not been evaluated by the FDA for safety, efficacy, or manufacturing standards equivalent to a U.S.-licensed pharmacy. No prescriber reviews your order before it ships. See our full explainer on how this model works.
The Healthymale offer, in full
Healthymale's $39/20-pill offer is run through Secure Medical and involves an online consultation with a licensed provider before anything ships. The specific medication and dosage are determined during that consultation, not chosen upfront from a catalog. See our full breakdown of what the offer includes.
These are not interchangeable options with the same regulatory backing. Choosing between them is a genuine trade-off — price and convenience against prescriber oversight and regulatory status — and we'd rather you make that choice with the full picture than have it obscured by convenient framing.
Why we're this direct about it
We make money on both kinds of links. Being vague about the difference would be easier and probably wouldn't cost us anything in the short term. We're stating it plainly anyway because we think the honest version of this trade-off is more useful to you than the sales-friendly version — and because it's the same standard we hold any pharmacy to in our evaluation checklist.
See our direct comparison of both paths, or the risk-factor list for who should skip straight to a prescriber.
Full active-ingredient, strength, and price comparison